Bills Tracker

← Back to Bills Tracker

Bill page

Controlled Drugs (Procedure for Specification) Bill

Controlled Drugs (Procedure for Specification) Bill has completed 1st reading on 2 Jul 2026 in the House of Commons. Parliament currently lists 2nd reading as its current stage.

Current position

Latest completed stage
1st reading2 Jul 2026
Current stage
2nd reading
House
House of Commons
Bill type
Private Members' Bill (Presentation Bill)
Last updated
14 Sep 2026
Proposer / sponsor
Matt Turmaine Proposer / sponsor · Labour · House of Commons

Parliamentary Calendar

Next scheduled stage

Provisional
2nd reading

· House of Commons

Future parliamentary business can change at short notice.

View in Parliamentary Calendar

What this bill is about

The Controlled Drugs (Procedure for Specification) Bill is intended to change the procedure for amending Schedule 2 to the Misuse of Drugs Act 1971, which lists controlled drugs. The bill’s available official material sets out that it focuses on how changes to that schedule are made, rather than introducing entirely new measures. It is a Private Members’ Bill introduced in the House of Commons and is still at an early stage, so more detailed provisions are not yet available in the sources provided.

What it would do

  • Change the procedure for amending Schedule 2 to the Misuse of Drugs Act 1971.
  • Schedule 2 is used to list controlled drugs, so the bill is about the mechanism for altering those listings.
  • The bill does not yet have supporting official bill text or explanatory notes in the provided sources.

Bill journey

Matched Commons vote groups are shown inside the relevant stage where the stored dates allow a match.

  1. 1st reading 2 Jul 2026 · House of Commons

Related daily summaries

Published daily summaries where this bill appears in the day’s parliamentary or government business.

2 summarys

Sources

Scroll to Top